Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Shanghai Junshi Biosciences Co., Ltd. has officially announced the re-election of its Board of Directors and Board of Supervisors as the terms for the current session expire. The new board restructure includes the appointment of 14 Directors, with 5 being independent non-executive Directors, as per the company’s Articles of Association. These changes come following the thirty-second meeting of the Board and aim to comply with relevant Chinese company laws and stock exchange rules.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.
